Bangalore, India · Founded 2017 · Privately Held (backing)
Developer of novel drugs designed to be used in vaccines for respiratory viruses. Mynvax is based in Bangalore, India and was founded in 2017. Its last known valuation is $29.8 million. It has raised $12.7 million.
Last price · $/share
—
Implied valuation
$29.8M
Total raised
$12.7M
Last round
—
Team — not yet on record
No current team members for Mynvax are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Mynvax with a free account
·The complete investor list: 15 names
·Watch Mynvax: the Monday email on marks, rounds and moves
